Sleep Disorders: Clinical Trials

1 trial for Sleep Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Sleep Disorders: new trials by email Literature Review of Sleep Disorders trials Research Report on Sleep Disorders

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
esmirtazapine - Sleep Initiation and Maintenance Disorders, Mental Disorders
Phase 3TerminatedMerck Sharp & Dohme LLC1842008-10-072021-02-02

Narrower conditions

Dyssomnias (1)  ·  Mental Disorders (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Mirtazapine (1)

Sponsors

Merck Sharp & Dohme LLC (1)

Results publications

PMID 32351205